Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate

Morgan, Rachel E.; Batot, Gaëlle O.; Dement, Jennifer M.; Rao, Vincenzo A.; Eadsforth, Thomas C.; Hunter, William N.
January 2011
BMC Structural Biology;2011, Vol. 11 Issue 1, p21
Academic Journal
Background: The enzyme dihydropteroate synthase (DHPS) participates in the de novo synthesis of folate cofactors by catalyzing the formation of 7,8-dihydropteroate from condensation of p-aminobenzoic acid with 6-hydroxymethyl-7,8-dihydropteroate pyrophosphate. DHPS is absent from humans, who acquire folates from diet, and has been validated as an antimicrobial therapeutic target by chemical and genetic means. The bacterium Burkholderia cenocepacia is an opportunistic pathogen and an infective agent of cystic fibrosis patients. The organism is highly resistant to antibiotics and there is a recognized need for the identification of new drugs against Burkholderia and related Gram-negative pathogens. Our characterization of the DHPS active site and interactions with the enzyme product are designed to underpin early stage drug discovery. Results: An efficient recombinant protein expression system for DHPS from B. cenocepacia (BcDHPS) was prepared, the dimeric enzyme purified in high yield and crystallized. The structure of the apo-enzyme and the complex with the product 7,8-dihydropteroate have been determined to 2.35 Ã… and 1.95 Ã… resolution respectively in distinct orthorhombic crystal forms. The latter represents the first crystal structure of the DHPS-pterin product complex, reveals key interactions involved in ligand binding, and reinforces data generated by other structural studies. Comparisons with orthologues identify plasticity near the substrate-binding pocket and in particular a range of loop conformations that contribute to the architecture of the DHPS active site. These structural data provide a foundation for hit discovery. An intriguing observation, an artifact of the analysis, that of a potential sulfenamide bond within the ligand complex structure is mentioned. Conclusion: Structural similarities between BcDHPS and orthologues from other Gram-negative species are evident as expected on the basis of a high level of sequence identity. The presence of 7,8-dihydropteroate in the binding site provides details about ligand recognition by the enzyme and the different states of the enzyme allow us to visualize distinct conformational states of loops adjacent to the active site. Improved drugs to combat infections by Burkholderia sp. and related Gram-negative bacteria are sought and our study now provides templates to assist that process and allow us to discuss new ways of inhibiting DHPS.


Related Articles

  • A disease called 'sixty-five roses'.  // Nature Structural Biology;Dec2002, Vol. 9 Issue 12, p887 

    Provides information on cystic fibrosis (CF). Cause of CF; Increase in efforts to educate the public about preventing CF; Initial screen for CF.

  • CYSTIC FIBROSIS NO LONGER A FATAL DISEASE. Braverman, Jane // Exceptional Parent;Nov2001, Vol. 31 Issue 11, p87 

    Provides information on cystic fibrosis. Background on the disease; Life expectancies of patients; Diagnosis of the illness; Treatment of the disease.

  • Activation of the epithelial Na+ channel (ENaC) requires CFTR CI- channel function. Reddy; Light, M.M. // Nature;11/18/1999, Vol. 402 Issue 6759, p301 

    Examines the ion channel regulation in the genetic disease cystic fibrosis. Dependence of epithelial Na+ channel on CFTR activity; Primary defect in Cl- channel permeability in cystic fibrosis; Factors in the reduced salt absorption in cystic fibrosis.

  • Genetic Data on Cystic Fibrosis (Mucoviscidosis).  // Clinical Pediatrics;Jun1972, Vol. 11 Issue 6, p333 

    Presents an abstract of a study about genetic data on cystic fibrosis by R. Gilly, M. Hermier, J. M. Robert, M. J. Challamel and G. Gery.

  • Cystic fibrosis: Low frequency of DF508 mutation in 2 population samples from Rio de Janeiro... Cabello, Giselda M.K.; Moreira, Adriana F. // Human Biology;Apr99, Vol. 71 Issue 2, p189 

    Examines blood samples from cystic fibrosis (CF) patients from Rio de Janeiro, Brazil for the 8 European CF mutations. One of the most common recessive single gene disorders in white individuals; Strategies for estimating CF incidence in Rio de Janeiro, Brazil.

  • Standards for clinical use of genetic variants.  // Nature Genetics;Feb2014, Vol. 46 Issue 2, p93 

    An introduction is presented in which the editor discusses various articles within the issue on topics including cystic fibrosis mutation database mutations, identifying mutations that impair the genome's ability to repair its DNA sequence, and statistical model for genetic disorders.

  • Testing for Cystic Fibrosis.  // Fertility Weekly;7/28/2003, p7 

    Describes the case in which a man was diagnosed with CBAVD after having two children by means of intracytoplasmic sperm. Implications for family planning, genetic counselling and systematic molecular testing for cystic fibrosis; Mutation screening for cystic fibrosis; Investigation of the...

  • Cystic fibrosis care guidelines launched.  // Australian Nursing Journal;Mar2000, Vol. 7 Issue 8, p12 

    Announces the launching of guidelines for the treatment of cystic fibrosis by the Clinical Standards Advisory Group of the Cystic Fibrosis Care Alliance (CFCA) in Victoria. Background information on CFCA; Benefits of the guidelines.

  • Make a Wish.  // Teen Ink;Apr2008, Vol. 19 Issue 8, p36 

    A personal narrative is presented which explores the author's experience of living with cystic fibrosis and being given a chance to make a wish through Make a Wish Foundation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics